

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 4.57829630 |
| 2 | carnitine shuttle (GO:0006853) | 4.56336375 |
| 3 | plasma membrane repair (GO:0001778) | 4.48758522 |
| 4 | fatty acid transmembrane transport (GO:1902001) | 4.48751895 |
| 5 | lysine catabolic process (GO:0006554) | 4.30491153 |
| 6 | lysine metabolic process (GO:0006553) | 4.30491153 |
| 7 | actin-myosin filament sliding (GO:0033275) | 4.18789726 |
| 8 | muscle filament sliding (GO:0030049) | 4.18789726 |
| 9 | 2-oxoglutarate metabolic process (GO:0006103) | 4.01916979 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 3.98368487 |
| 11 | focal adhesion assembly (GO:0048041) | 3.96815809 |
| 12 | cell-substrate adherens junction assembly (GO:0007045) | 3.96815809 |
| 13 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.94660676 |
| 14 | cell-substrate junction assembly (GO:0007044) | 3.94458738 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.92770048 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.92231451 |
| 17 | hemidesmosome assembly (GO:0031581) | 3.90967482 |
| 18 | cardiac myofibril assembly (GO:0055003) | 3.87818714 |
| 19 | skeletal muscle contraction (GO:0003009) | 3.80345943 |
| 20 | adherens junction assembly (GO:0034333) | 3.80199760 |
| 21 | regulation of sequestering of triglyceride (GO:0010889) | 3.76168517 |
| 22 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.75230161 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 3.75089409 |
| 24 | myofibril assembly (GO:0030239) | 3.70852392 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.58726320 |
| 26 | tricarboxylic acid cycle (GO:0006099) | 3.58111765 |
| 27 | actin-mediated cell contraction (GO:0070252) | 3.52701787 |
| 28 | carnitine transmembrane transport (GO:1902603) | 3.52385410 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 3.52309044 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.51379073 |
| 31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50560242 |
| 32 | regulation of fatty acid oxidation (GO:0046320) | 3.48796859 |
| 33 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.44698015 |
| 34 | positive regulation of fatty acid oxidation (GO:0046321) | 3.42580134 |
| 35 | amino-acid betaine transport (GO:0015838) | 3.41554028 |
| 36 | carnitine transport (GO:0015879) | 3.41554028 |
| 37 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.39768881 |
| 38 | fatty acid oxidation (GO:0019395) | 3.36937608 |
| 39 | acetyl-CoA metabolic process (GO:0006084) | 3.34598013 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.33805777 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 3.33659827 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.33659827 |
| 43 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.30796456 |
| 44 | lipid oxidation (GO:0034440) | 3.30535306 |
| 45 | L-phenylalanine catabolic process (GO:0006559) | 3.28896546 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.28896546 |
| 47 | response to muscle activity (GO:0014850) | 3.27634752 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 3.25721138 |
| 49 | fatty acid catabolic process (GO:0009062) | 3.25295029 |
| 50 | regulation of the force of heart contraction (GO:0002026) | 3.23790211 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.22563208 |
| 52 | regulation of actin filament-based movement (GO:1903115) | 3.21823407 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.20007785 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.20004301 |
| 55 | epithelial cell-cell adhesion (GO:0090136) | 3.14982341 |
| 56 | cardiac muscle contraction (GO:0060048) | 3.12268879 |
| 57 | regulation of relaxation of muscle (GO:1901077) | 3.12244810 |
| 58 | actomyosin structure organization (GO:0031032) | 3.12111191 |
| 59 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11821656 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.10139680 |
| 61 | muscle contraction (GO:0006936) | 3.09639306 |
| 62 | desmosome organization (GO:0002934) | 3.08233975 |
| 63 | low-density lipoprotein particle clearance (GO:0034383) | 3.07947284 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.07672232 |
| 65 | carnitine metabolic process (GO:0009437) | 3.07299698 |
| 66 | creatine metabolic process (GO:0006600) | 3.05167941 |
| 67 | cardiac muscle hypertrophy (GO:0003300) | 3.04995584 |
| 68 | valine metabolic process (GO:0006573) | 3.04186684 |
| 69 | phospholipid homeostasis (GO:0055091) | 3.04011495 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.04003720 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.03700454 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 2.98654717 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98516370 |
| 74 | monocarboxylic acid catabolic process (GO:0072329) | 2.97997463 |
| 75 | tricarboxylic acid metabolic process (GO:0072350) | 2.96283249 |
| 76 | positive regulation of lipid catabolic process (GO:0050996) | 2.95725816 |
| 77 | actin filament-based movement (GO:0030048) | 2.95369310 |
| 78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95104752 |
| 79 | striated muscle hypertrophy (GO:0014897) | 2.91982570 |
| 80 | cysteine metabolic process (GO:0006534) | 2.91948991 |
| 81 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.90315244 |
| 82 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.89929778 |
| 83 | ethanol oxidation (GO:0006069) | 2.89527070 |
| 84 | plasma lipoprotein particle clearance (GO:0034381) | 2.89370351 |
| 85 | cardiac muscle cell development (GO:0055013) | 2.87624407 |
| 86 | biotin metabolic process (GO:0006768) | 2.84281997 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 2.83742709 |
| 88 | protein carboxylation (GO:0018214) | 2.82794216 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82794216 |
| 90 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.82607973 |
| 91 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.81364753 |
| 92 | cell communication by electrical coupling (GO:0010644) | 2.81023958 |
| 93 | NADH metabolic process (GO:0006734) | 2.80438377 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 2.80295713 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 2.79080554 |
| 96 | muscle tissue morphogenesis (GO:0060415) | 2.78777904 |
| 97 | regulation of cell communication by electrical coupling (GO:0010649) | 2.77885365 |
| 98 | complement activation, alternative pathway (GO:0006957) | 2.77539248 |
| 99 | striated muscle contraction (GO:0006941) | 2.76678020 |
| 100 | quaternary ammonium group transport (GO:0015697) | 2.74466468 |
| 101 | glycogen catabolic process (GO:0005980) | 2.74432188 |
| 102 | muscle system process (GO:0003012) | 2.74238242 |
| 103 | homocysteine metabolic process (GO:0050667) | 2.74162053 |
| 104 | protein localization to endosome (GO:0036010) | 2.73330884 |
| 105 | cardiac cell development (GO:0055006) | 2.72306852 |
| 106 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71869780 |
| 107 | skeletal muscle fiber development (GO:0048741) | 2.70478025 |
| 108 | basement membrane organization (GO:0071711) | 2.69283023 |
| 109 | regulation of fibrinolysis (GO:0051917) | 2.67870678 |
| 110 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.67824766 |
| 111 | skeletal muscle adaptation (GO:0043501) | 2.66452832 |
| 112 | cell communication involved in cardiac conduction (GO:0086065) | 2.65460971 |
| 113 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.65165005 |
| 114 | glucan catabolic process (GO:0009251) | 2.65089631 |
| 115 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64731193 |
| 116 | negative regulation of cell size (GO:0045792) | 2.64678995 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.64383438 |
| 118 | regulation of early endosome to late endosome transport (GO:2000641) | 2.64362091 |
| 119 | fatty acid homeostasis (GO:0055089) | 2.64335195 |
| 120 | intracellular lipid transport (GO:0032365) | 2.63618523 |
| 121 | cellular modified amino acid catabolic process (GO:0042219) | 2.63488432 |
| 122 | striated muscle adaptation (GO:0014888) | 2.62908377 |
| 123 | heart trabecula formation (GO:0060347) | 2.61382464 |
| 124 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61217399 |
| 125 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.61214125 |
| 126 | bile acid biosynthetic process (GO:0006699) | 2.60852067 |
| 127 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.59714219 |
| 128 | negative regulation of fatty acid transport (GO:2000192) | 2.58836428 |
| 129 | regulation of protein activation cascade (GO:2000257) | 2.58667533 |
| 130 | regulation of p38MAPK cascade (GO:1900744) | 2.58403792 |
| 131 | triglyceride homeostasis (GO:0070328) | 2.58147002 |
| 132 | acylglycerol homeostasis (GO:0055090) | 2.58147002 |
| 133 | response to mercury ion (GO:0046689) | 2.56837520 |
| 134 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56482896 |
| 135 | muscle hypertrophy (GO:0014896) | 2.53032722 |
| 136 | gap junction assembly (GO:0016264) | 2.52674336 |
| 137 | barbed-end actin filament capping (GO:0051016) | 2.50748003 |
| 138 | positive regulation of myotube differentiation (GO:0010831) | 2.50679840 |
| 139 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.49564174 |
| 140 | response to inactivity (GO:0014854) | 2.49066212 |
| 141 | striated muscle atrophy (GO:0014891) | 2.48784692 |
| 142 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48550845 |
| 143 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.47963954 |
| 144 | sodium ion export (GO:0071436) | 2.45273053 |
| 145 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.45108993 |
| 146 | stress fiber assembly (GO:0043149) | 2.43789297 |
| 147 | skin morphogenesis (GO:0043589) | 2.39093939 |
| 148 | cardiac muscle adaptation (GO:0014887) | 2.37962658 |
| 149 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.37962658 |
| 150 | muscle hypertrophy in response to stress (GO:0003299) | 2.37962658 |
| 151 | atrioventricular valve morphogenesis (GO:0003181) | 2.36634112 |
| 152 | myoblast fusion (GO:0007520) | 2.36605391 |
| 153 | gluconeogenesis (GO:0006094) | 2.36515417 |
| 154 | endothelial cell morphogenesis (GO:0001886) | 2.34380824 |
| 155 | COPI coating of Golgi vesicle (GO:0048205) | 2.32204791 |
| 156 | Golgi transport vesicle coating (GO:0048200) | 2.32204791 |
| 157 | actin filament depolymerization (GO:0030042) | 2.30919994 |
| 158 | endodermal cell differentiation (GO:0035987) | 2.29561756 |
| 159 | cellular polysaccharide catabolic process (GO:0044247) | 2.28467366 |
| 160 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28054687 |
| 161 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.27716799 |
| 162 | regulation of striated muscle contraction (GO:0006942) | 2.27606108 |
| 163 | regulation of cardioblast differentiation (GO:0051890) | 2.26489735 |
| 164 | positive regulation of receptor recycling (GO:0001921) | 2.26308860 |
| 165 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26233647 |
| 166 | regulation of tight junction assembly (GO:2000810) | 2.26116022 |
| 167 | protein targeting to plasma membrane (GO:0072661) | 2.24630141 |
| 168 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.23328599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.76350000 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.64015124 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.15704614 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.84469150 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.78134187 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59161646 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.95246149 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.90569677 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.82623778 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.67285197 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57772629 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.27764015 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.23293610 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15952672 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.05576376 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00431328 |
| 17 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.97919365 |
| 18 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.97919365 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93625280 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.92691693 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82248187 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78679939 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74514547 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70214230 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66391373 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64651633 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57183964 |
| 28 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.57124308 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56374929 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53087875 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49311621 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48702941 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44241964 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43871400 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41886180 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40554280 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38091199 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37861772 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.36864339 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36396059 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35701372 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35553830 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33868966 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.32940961 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32722792 |
| 46 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31837090 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31584486 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29944931 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27497998 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26687071 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26506137 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24727069 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23455696 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22825072 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21864594 |
| 56 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21372014 |
| 57 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.21221953 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20414702 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20010914 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19540267 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17586275 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17584987 |
| 63 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17498477 |
| 64 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17472263 |
| 65 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.17076680 |
| 66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16356683 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16032865 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15767383 |
| 69 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.15754006 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13329801 |
| 71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12653986 |
| 72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12210610 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.11737837 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10647475 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08558219 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08434683 |
| 77 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07639230 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07161353 |
| 79 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05818813 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04614887 |
| 81 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04465534 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02940825 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02525714 |
| 84 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02282176 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01883230 |
| 86 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99950827 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99863971 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99863971 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99783680 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99771684 |
| 91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97787300 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97159303 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96665076 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96440696 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95710928 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93782995 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93482603 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93407618 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92944363 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92076681 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91924260 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91754793 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89849752 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89317687 |
| 105 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.89249048 |
| 106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88898786 |
| 107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88898786 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88726941 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87814480 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87121045 |
| 111 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86281842 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84722916 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84313059 |
| 114 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83913628 |
| 115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82981952 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82883457 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82822034 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82070285 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81793916 |
| 120 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.81270125 |
| 121 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80102934 |
| 122 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79865950 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79576505 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79453525 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79088907 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78458934 |
| 127 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78336378 |
| 128 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.77539350 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77477837 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76389782 |
| 131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75757439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.22234769 |
| 2 | MP0000751_myopathy | 3.47806714 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.41510328 |
| 4 | MP0005360_urolithiasis | 3.31863448 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.23373379 |
| 6 | MP0003646_muscle_fatigue | 3.21441865 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.99507226 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.70851393 |
| 9 | MP0004130_abnormal_muscle_cell | 2.70610745 |
| 10 | MP0000749_muscle_degeneration | 2.69797478 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.59142016 |
| 12 | MP0005365_abnormal_bile_salt | 2.46356899 |
| 13 | MP0005330_cardiomyopathy | 2.40702845 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.33449765 |
| 15 | MP0005275_abnormal_skin_tensile | 2.32049601 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.29772215 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.19971408 |
| 18 | MP0003252_abnormal_bile_duct | 2.04539991 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.02925641 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.02452570 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91308003 |
| 22 | MP0009840_abnormal_foam_cell | 1.88572312 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.88416432 |
| 24 | MP0005670_abnormal_white_adipose | 1.87345534 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.85005777 |
| 26 | MP0005620_abnormal_muscle_contractility | 1.83140437 |
| 27 | MP0005409_darkened_coat_color | 1.81116696 |
| 28 | MP0002269_muscular_atrophy | 1.80631746 |
| 29 | MP0000747_muscle_weakness | 1.78271541 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.76047746 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.75680585 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.69630084 |
| 33 | MP0002106_abnormal_muscle_physiology | 1.68094841 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.67267504 |
| 35 | MP0005083_abnormal_biliary_tract | 1.64443417 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.62290395 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.60914345 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.58673052 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.58673052 |
| 40 | MP0000759_abnormal_skeletal_muscle | 1.57387186 |
| 41 | MP0006138_congestive_heart_failure | 1.55755480 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.53943818 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.51682688 |
| 44 | MP0002796_impaired_skin_barrier | 1.49615597 |
| 45 | MP0001849_ear_inflammation | 1.46935362 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.46423107 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.46163653 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.45688804 |
| 49 | MP0004858_abnormal_nervous_system | 1.45637420 |
| 50 | MP0005332_abnormal_amino_acid | 1.41201459 |
| 51 | MP0005369_muscle_phenotype | 1.40323131 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.32442651 |
| 53 | MP0003195_calcinosis | 1.31821416 |
| 54 | MP0000762_abnormal_tongue_morphology | 1.31484315 |
| 55 | MP0004272_abnormal_basement_membrane | 1.30922706 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.30182541 |
| 57 | MP0003941_abnormal_skin_development | 1.29951837 |
| 58 | MP0003091_abnormal_cell_migration | 1.29733251 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.27009807 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.24602189 |
| 61 | MP0004484_altered_response_of | 1.22166703 |
| 62 | MP0002971_abnormal_brown_adipose | 1.17862752 |
| 63 | MP0001661_extended_life_span | 1.17179889 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.16921548 |
| 65 | MP0003279_aneurysm | 1.15835965 |
| 66 | MP0010030_abnormal_orbit_morphology | 1.14809974 |
| 67 | MP0000609_abnormal_liver_physiology | 1.11992356 |
| 68 | MP0000467_abnormal_esophagus_morphology | 1.09322685 |
| 69 | MP0002060_abnormal_skin_morphology | 1.06100051 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.05762542 |
| 71 | MP0004233_abnormal_muscle_weight | 1.04924602 |
| 72 | MP0003828_pulmonary_edema | 1.04026658 |
| 73 | MP0005503_abnormal_tendon_morphology | 1.03223183 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.02616878 |
| 75 | MP0001299_abnormal_eye_distance/ | 1.01814223 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01458552 |
| 77 | MP0000733_abnormal_muscle_development | 1.01312583 |
| 78 | MP0005451_abnormal_body_composition | 1.01011410 |
| 79 | MP0001958_emphysema | 1.00935427 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.99677969 |
| 81 | MP0009384_cardiac_valve_regurgitation | 0.97880686 |
| 82 | MP0002127_abnormal_cardiovascular_syste | 0.97362567 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.96875352 |
| 84 | MP0002108_abnormal_muscle_morphology | 0.96630308 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.95851526 |
| 86 | MP0005623_abnormal_meninges_morphology | 0.92664057 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.91653881 |
| 88 | MP0004270_analgesia | 0.91165541 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.90135285 |
| 90 | MP0000579_abnormal_nail_morphology | 0.90073902 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.89996383 |
| 92 | MP0004085_abnormal_heartbeat | 0.89056880 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.86572512 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86296689 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.86162775 |
| 96 | MP0002254_reproductive_system_inflammat | 0.85224329 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.84613249 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.84423155 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.83569183 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.83480527 |
| 101 | MP0000343_altered_response_to | 0.82515827 |
| 102 | MP0003329_amyloid_beta_deposits | 0.81631961 |
| 103 | MP0004510_myositis | 0.81391959 |
| 104 | MP0003879_abnormal_hair_cell | 0.79700052 |
| 105 | MP0005165_increased_susceptibility_to | 0.78695389 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.78590133 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.78076304 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.77324217 |
| 109 | MP0000566_synostosis | 0.76178372 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.74624028 |
| 111 | MP0002249_abnormal_larynx_morphology | 0.74539894 |
| 112 | MP0005334_abnormal_fat_pad | 0.73388988 |
| 113 | MP0002128_abnormal_blood_circulation | 0.73215932 |
| 114 | MP0003045_fibrosis | 0.72894632 |
| 115 | MP0005501_abnormal_skin_physiology | 0.72550358 |
| 116 | MP0005023_abnormal_wound_healing | 0.70036045 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.69762091 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.69497909 |
| 119 | MP0000266_abnormal_heart_morphology | 0.69417334 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.68021160 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.67444723 |
| 122 | MP0009115_abnormal_fat_cell | 0.67027352 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.66218899 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.65305608 |
| 125 | MP0008260_abnormal_autophagy | 0.63346795 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.63052883 |
| 127 | MP0000462_abnormal_digestive_system | 0.62840185 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.62401142 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.61828315 |
| 130 | MP0009780_abnormal_chondrocyte_physiolo | 0.60665468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.86936603 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.76632604 |
| 3 | Sudden death (HP:0001699) | 4.70910934 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 4.69500986 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 4.49153806 |
| 6 | Increased connective tissue (HP:0009025) | 4.44003284 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.43638001 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.24515386 |
| 9 | Myoglobinuria (HP:0002913) | 4.24163310 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 3.98757382 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.83334005 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.80088819 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 3.74561971 |
| 14 | Difficulty running (HP:0009046) | 3.68291757 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 3.42035170 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.31762339 |
| 17 | Rhabdomyolysis (HP:0003201) | 3.21619966 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.19414524 |
| 19 | Asymmetric septal hypertrophy (HP:0001670) | 3.19235737 |
| 20 | Xanthomatosis (HP:0000991) | 3.18167885 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 3.17434539 |
| 22 | Lipoatrophy (HP:0100578) | 3.10045708 |
| 23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.09985125 |
| 24 | Subaortic stenosis (HP:0001682) | 3.00620611 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.00620611 |
| 26 | Hypoglycemic coma (HP:0001325) | 2.93804389 |
| 27 | Difficulty climbing stairs (HP:0003551) | 2.90364084 |
| 28 | Ketosis (HP:0001946) | 2.90274641 |
| 29 | Ketoacidosis (HP:0001993) | 2.90176386 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.88905769 |
| 31 | Atrial fibrillation (HP:0005110) | 2.85888962 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 2.80612724 |
| 33 | Bundle branch block (HP:0011710) | 2.76979172 |
| 34 | Lower limb amyotrophy (HP:0007210) | 2.71435765 |
| 35 | Hyperammonemia (HP:0001987) | 2.70285032 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.70268506 |
| 37 | Hyperglycinuria (HP:0003108) | 2.70113120 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.64278522 |
| 39 | Primary atrial arrhythmia (HP:0001692) | 2.63524915 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 2.63365250 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.62977807 |
| 42 | Muscle stiffness (HP:0003552) | 2.58913449 |
| 43 | Round ear (HP:0100830) | 2.56453631 |
| 44 | Palpitations (HP:0001962) | 2.54692263 |
| 45 | Atrioventricular block (HP:0001678) | 2.53029983 |
| 46 | Myotonia (HP:0002486) | 2.51144796 |
| 47 | Supraventricular arrhythmia (HP:0005115) | 2.49274488 |
| 48 | Syncope (HP:0001279) | 2.48858534 |
| 49 | Ventricular arrhythmia (HP:0004308) | 2.47943484 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.47313098 |
| 51 | Nemaline bodies (HP:0003798) | 2.46424060 |
| 52 | Broad metatarsal (HP:0001783) | 2.45949212 |
| 53 | Abnormal atrioventricular conduction (HP:0005150) | 2.44559697 |
| 54 | Heart block (HP:0012722) | 2.42870141 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.42730208 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42730208 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.41275584 |
| 58 | Protrusio acetabuli (HP:0003179) | 2.37498740 |
| 59 | Distal lower limb muscle weakness (HP:0009053) | 2.36243325 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36054188 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.32517257 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.30882147 |
| 63 | Complement deficiency (HP:0004431) | 2.29291812 |
| 64 | Conjunctival hamartoma (HP:0100780) | 2.24385204 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 2.24328823 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.22888340 |
| 67 | Foot dorsiflexor weakness (HP:0009027) | 2.22122089 |
| 68 | Atrophic scars (HP:0001075) | 2.21274453 |
| 69 | Hyperacusis (HP:0010780) | 2.20554515 |
| 70 | Bulbar palsy (HP:0001283) | 2.17892261 |
| 71 | Skin nodule (HP:0200036) | 2.17079111 |
| 72 | Fragile skin (HP:0001030) | 2.16846174 |
| 73 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16769172 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 2.15602250 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.13306469 |
| 76 | Cholelithiasis (HP:0001081) | 2.12227512 |
| 77 | Epidermoid cyst (HP:0200040) | 2.12198044 |
| 78 | Aortic aneurysm (HP:0004942) | 2.10748700 |
| 79 | Distal arthrogryposis (HP:0005684) | 2.10106296 |
| 80 | Shallow orbits (HP:0000586) | 2.09980113 |
| 81 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09579963 |
| 82 | Gout (HP:0001997) | 2.09484517 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.09045890 |
| 84 | Myopathic facies (HP:0002058) | 2.07982142 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07622711 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.07622711 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.07313980 |
| 88 | Achilles tendon contracture (HP:0001771) | 2.07157617 |
| 89 | Lymphangioma (HP:0100764) | 2.06809337 |
| 90 | Rimmed vacuoles (HP:0003805) | 2.05849595 |
| 91 | Calcaneovalgus deformity (HP:0001848) | 2.05826754 |
| 92 | Myocardial infarction (HP:0001658) | 2.05615144 |
| 93 | Scapular winging (HP:0003691) | 2.04435986 |
| 94 | Slender build (HP:0001533) | 2.03821547 |
| 95 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00628690 |
| 96 | Spinal rigidity (HP:0003306) | 1.99857366 |
| 97 | Ventricular fibrillation (HP:0001663) | 1.98920935 |
| 98 | Prolonged QT interval (HP:0001657) | 1.98083838 |
| 99 | Vascular tortuosity (HP:0004948) | 1.97705248 |
| 100 | Limb-girdle muscle atrophy (HP:0003797) | 1.97574792 |
| 101 | Ulnar bowing (HP:0003031) | 1.96710236 |
| 102 | Hyperglycinemia (HP:0002154) | 1.93824456 |
| 103 | Arterial tortuosity (HP:0005116) | 1.93431718 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 1.92326932 |
| 105 | Facial diplegia (HP:0001349) | 1.91316237 |
| 106 | Neck muscle weakness (HP:0000467) | 1.89548975 |
| 107 | Back pain (HP:0003418) | 1.89129806 |
| 108 | Generalized muscle weakness (HP:0003324) | 1.88615969 |
| 109 | Hamartoma of the eye (HP:0010568) | 1.87298236 |
| 110 | Generalized amyotrophy (HP:0003700) | 1.86548038 |
| 111 | Vertebral compression fractures (HP:0002953) | 1.86383745 |
| 112 | Dysmetric saccades (HP:0000641) | 1.85800723 |
| 113 | Hypoplastic ischia (HP:0003175) | 1.84615322 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 1.84031764 |
| 115 | Areflexia of lower limbs (HP:0002522) | 1.82695351 |
| 116 | Hypobetalipoproteinemia (HP:0003563) | 1.82091987 |
| 117 | Aneurysm (HP:0002617) | 1.80894986 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 1.80470513 |
| 119 | Upper limb amyotrophy (HP:0009129) | 1.80470513 |
| 120 | Ankle contracture (HP:0006466) | 1.79038605 |
| 121 | Advanced eruption of teeth (HP:0006288) | 1.78309949 |
| 122 | Deformed tarsal bones (HP:0008119) | 1.76456297 |
| 123 | Ulnar deviation of the wrist (HP:0003049) | 1.76192923 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.75418073 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.75418073 |
| 126 | Stridor (HP:0010307) | 1.74649539 |
| 127 | Hyperglycemia (HP:0003074) | 1.74354005 |
| 128 | Bladder diverticulum (HP:0000015) | 1.74157601 |
| 129 | Wormian bones (HP:0002645) | 1.73976793 |
| 130 | EMG: neuropathic changes (HP:0003445) | 1.73938146 |
| 131 | Abnormality of the calcaneus (HP:0008364) | 1.73717720 |
| 132 | Obstructive sleep apnea (HP:0002870) | 1.69802675 |
| 133 | Aortic dissection (HP:0002647) | 1.68920364 |
| 134 | Gowers sign (HP:0003391) | 1.68366387 |
| 135 | Malignant hyperthermia (HP:0002047) | 1.68114951 |
| 136 | Flat acetabular roof (HP:0003180) | 1.67115280 |
| 137 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65981582 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.65981582 |
| 139 | Hip contracture (HP:0003273) | 1.65766575 |
| 140 | Muscular dystrophy (HP:0003560) | 1.64002044 |
| 141 | Broad face (HP:0000283) | 1.63419881 |
| 142 | Limb-girdle muscle weakness (HP:0003325) | 1.61259397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.12360143 |
| 2 | TRIB3 | 4.40212193 |
| 3 | PKN2 | 3.27268932 |
| 4 | OBSCN | 2.89732579 |
| 5 | BCKDK | 2.76158379 |
| 6 | PHKG1 | 2.58824121 |
| 7 | PHKG2 | 2.58824121 |
| 8 | SIK1 | 2.33057229 |
| 9 | LMTK2 | 2.27153531 |
| 10 | ERN1 | 2.24891363 |
| 11 | RIPK1 | 2.16064329 |
| 12 | PDK4 | 2.05621157 |
| 13 | PDK3 | 2.05621157 |
| 14 | DMPK | 2.02675189 |
| 15 | LATS1 | 1.83625508 |
| 16 | SMG1 | 1.79513396 |
| 17 | PRPF4B | 1.68786569 |
| 18 | PDGFRA | 1.67842513 |
| 19 | IRAK3 | 1.65338716 |
| 20 | PTK6 | 1.64019730 |
| 21 | MYLK | 1.60326116 |
| 22 | MAP3K7 | 1.48889674 |
| 23 | FGFR4 | 1.47074067 |
| 24 | PIK3CA | 1.43375890 |
| 25 | NEK1 | 1.38095069 |
| 26 | TIE1 | 1.35827700 |
| 27 | MST1R | 1.33095392 |
| 28 | TESK1 | 1.32759410 |
| 29 | MAP2K3 | 1.32632699 |
| 30 | PDK2 | 1.29409883 |
| 31 | EPHB1 | 1.28167649 |
| 32 | CDK12 | 1.19461076 |
| 33 | MAP3K3 | 1.19127088 |
| 34 | NTRK1 | 1.19126474 |
| 35 | PINK1 | 1.17552478 |
| 36 | PIK3CG | 1.16846457 |
| 37 | DDR2 | 1.16202639 |
| 38 | CAMK1D | 1.14300314 |
| 39 | FER | 1.13572723 |
| 40 | LIMK1 | 1.13057953 |
| 41 | PAK3 | 1.09894588 |
| 42 | TGFBR2 | 1.02903031 |
| 43 | EPHB2 | 1.01202365 |
| 44 | NEK9 | 1.00648930 |
| 45 | PRKD1 | 1.00244255 |
| 46 | PRKAA2 | 0.99870354 |
| 47 | BMX | 0.99629988 |
| 48 | ARAF | 0.99415782 |
| 49 | MUSK | 0.96522642 |
| 50 | MAPKAPK3 | 0.95250911 |
| 51 | LRRK2 | 0.94444766 |
| 52 | CAMK1G | 0.87643866 |
| 53 | LATS2 | 0.85611670 |
| 54 | TRPM7 | 0.85460289 |
| 55 | EEF2K | 0.85270436 |
| 56 | CAMK2G | 0.85024753 |
| 57 | RPS6KA2 | 0.84447333 |
| 58 | MAP3K10 | 0.82824006 |
| 59 | ICK | 0.81487851 |
| 60 | MAPK12 | 0.80387602 |
| 61 | MAP3K6 | 0.78870477 |
| 62 | MAP3K9 | 0.77725363 |
| 63 | MAP3K13 | 0.76708233 |
| 64 | PTK2 | 0.76655137 |
| 65 | STK38 | 0.76277428 |
| 66 | ROCK1 | 0.76227157 |
| 67 | MET | 0.76002203 |
| 68 | PRKAA1 | 0.74684413 |
| 69 | STK38L | 0.70516026 |
| 70 | MOS | 0.70010486 |
| 71 | INSRR | 0.69731526 |
| 72 | WNK4 | 0.69722277 |
| 73 | TAOK2 | 0.68747328 |
| 74 | ILK | 0.67353929 |
| 75 | MTOR | 0.66060749 |
| 76 | PRKD2 | 0.66040300 |
| 77 | MAP2K4 | 0.65896927 |
| 78 | JAK1 | 0.65589371 |
| 79 | FLT3 | 0.65385577 |
| 80 | CAMK2B | 0.62319162 |
| 81 | ROCK2 | 0.61751602 |
| 82 | MARK2 | 0.60746861 |
| 83 | EPHA2 | 0.60630674 |
| 84 | PAK2 | 0.60412448 |
| 85 | PDPK1 | 0.60295771 |
| 86 | MAPK11 | 0.60266480 |
| 87 | TAOK1 | 0.59588303 |
| 88 | RET | 0.59567472 |
| 89 | PAK6 | 0.58955018 |
| 90 | MAP2K1 | 0.58106711 |
| 91 | FRK | 0.56365013 |
| 92 | RPS6KB2 | 0.55338414 |
| 93 | FGFR2 | 0.55217264 |
| 94 | PDGFRB | 0.54628093 |
| 95 | FGFR3 | 0.53870973 |
| 96 | PTK2B | 0.52653892 |
| 97 | STK24 | 0.52638749 |
| 98 | PRKCH | 0.52465840 |
| 99 | RPS6KL1 | 0.51234901 |
| 100 | RPS6KC1 | 0.51234901 |
| 101 | KDR | 0.48336069 |
| 102 | DYRK1B | 0.48025722 |
| 103 | CAMK2D | 0.47534676 |
| 104 | KSR2 | 0.46930960 |
| 105 | DAPK3 | 0.46890016 |
| 106 | JAK2 | 0.45586899 |
| 107 | FGFR1 | 0.45434415 |
| 108 | SCYL2 | 0.44968840 |
| 109 | MAP3K5 | 0.43868786 |
| 110 | PAK4 | 0.43618543 |
| 111 | CDC42BPA | 0.43202758 |
| 112 | PRKG2 | 0.43045065 |
| 113 | WNK1 | 0.42957708 |
| 114 | MAP3K1 | 0.42545156 |
| 115 | PRKD3 | 0.42346713 |
| 116 | SGK3 | 0.42208356 |
| 117 | CDK6 | 0.41907705 |
| 118 | MAPK4 | 0.41782138 |
| 119 | ERBB4 | 0.41369630 |
| 120 | TBK1 | 0.41105407 |
| 121 | ABL2 | 0.40057047 |
| 122 | BRAF | 0.37799941 |
| 123 | MAP3K2 | 0.37539277 |
| 124 | EPHA3 | 0.37209504 |
| 125 | GSK3A | 0.37193036 |
| 126 | MAPK7 | 0.37030937 |
| 127 | AKT2 | 0.36902543 |
| 128 | PRKACG | 0.36355770 |
| 129 | CAMK4 | 0.35959598 |
| 130 | TYK2 | 0.35956838 |
| 131 | PDK1 | 0.34385772 |
| 132 | TYRO3 | 0.34360255 |
| 133 | RPS6KA6 | 0.33622860 |
| 134 | MAPK10 | 0.33601280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45500640 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.09384672 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.08254396 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.01385196 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85197712 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75875916 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59123355 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44137313 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.38686000 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.38635831 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24601091 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21638091 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04183069 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.95711555 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89165125 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85523420 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70476622 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.65734825 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.65443549 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63358139 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62761225 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52776222 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50170456 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47453796 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41043432 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.38106173 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.36221505 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33088378 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25173901 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23991914 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21318657 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19687860 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18536380 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14210246 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.14058848 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13981622 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13796888 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13290767 |
| 39 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.13055977 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.11232381 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10904257 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09944303 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08930104 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08566917 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07504245 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06028858 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.04714756 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96635008 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94295114 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93007515 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.92144744 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91584075 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89566127 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88560911 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88282380 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87600470 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86717155 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85603421 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83853487 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83040665 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.81925226 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81901262 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.80151184 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79395466 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79030808 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78740140 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77675529 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.77222753 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76335952 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75912280 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74952881 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73135703 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72344397 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71573474 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71234678 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70925881 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70575356 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.70005829 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69620885 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68446419 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.67069151 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66429709 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66221134 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65972880 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63617725 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60712279 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.60173092 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57134667 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57110319 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57005941 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56948536 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55496477 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55467384 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55141730 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54668506 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53391464 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53167605 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53162961 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52793113 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52779712 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.52310595 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51408871 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49959283 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49220649 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47756638 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47571790 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.47540423 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46901470 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.45130112 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44720544 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44554113 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44304994 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43142504 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42698558 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.41722706 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41219751 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40739520 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37343687 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35181521 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34509738 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34160401 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.33835809 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33131918 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32437925 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31010797 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29256758 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27977766 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27339525 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25826104 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25496208 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21610649 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20946115 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20462566 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19569260 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19407689 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.17517538 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15507651 |
| 138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15200349 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14575310 |
| 140 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13819757 |

